|By PR Newswire||
|February 24, 2014 08:02 AM EST||
DUBLIN, Feb. 24, 2014
/PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/4hbsm6/pain_management) has announced the addition of the "Concise Analysis of the International Pain Management Therapeutics Market - Forecasts to 2018" report to their offering.
This report studies the global market for pain management therapeutics from three perspectives - therapeutic classes of drugs, indications and geography. Each of these segments is further classified into sub-segments; therapeutic classes include anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic analgesics.
The various pain management indications studied in this report include neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments in terms of USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.
Geographically, the market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section of the report provides a detailed breakdown of various aspects of market dynamics such as drivers, restraints and opportunities along with market attractiveness analysis and Porter's five force analysis for the pain management therapeutics market.
The competitive landscape section includes market share analysis of all the leading players in the branded pharmaceuticals market for pain management, in terms of percentage share in the year 2011.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Pain Management Therapeutics Market, by Therapeutic Class
5 Global Pain Management Therapeutics Market, by Indication
6 Global Pain Management Therapeutics Market, by Geography
7 Competitive Landscape
9 Company Profiles
- Abbott Laboratories
- Durect Corporation
- Eli Lilly and Company
- Endo Health Solutions
- Forest Laboratories
- Johnson & Johnson
- Merck & Co
- Mundipharma International
- Novartis International
- Pain Therapeutics
- Purdue Pharma
- QRx Pharma
- Teva Pharmaceutical Industries
- UCB (Union Chemnique Belge)
For more information visit http://www.researchandmarkets.com/research/4hbsm6/pain_management
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
Sep. 24, 2016 06:30 PM EDT Reads: 1,558
Sep. 24, 2016 04:30 PM EDT Reads: 1,483
Sep. 24, 2016 04:30 PM EDT Reads: 1,676
Sep. 24, 2016 04:00 PM EDT Reads: 1,512
Sep. 24, 2016 03:45 PM EDT Reads: 1,411
Sep. 24, 2016 03:00 PM EDT Reads: 1,013
Sep. 24, 2016 02:15 PM EDT Reads: 1,178
Sep. 24, 2016 02:00 PM EDT Reads: 1,624
Sep. 24, 2016 01:30 PM EDT Reads: 1,670
Sep. 24, 2016 01:00 PM EDT Reads: 1,471
Sep. 24, 2016 12:00 PM EDT Reads: 730
Sep. 24, 2016 12:00 PM EDT Reads: 741
Sep. 24, 2016 11:45 AM EDT Reads: 1,015
Sep. 24, 2016 11:00 AM EDT Reads: 945
SYS-CON Events announced today that Secure Channels will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The bedrock of Secure Channels Technology is a uniquely modified and enhanced process based on superencipherment. Superencipherment is the process of encrypting an already encrypted message one or more times, either using the same or a different algorithm.
Sep. 24, 2016 10:45 AM EDT Reads: 1,396